Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Trebananib

EU orphan designation number: EU/3/13/1207   
Active ingredient: Trebananib
Indication: Treatment of ovarian cancer
Sponsor: Amgen Europe B.V.
Minervum 7061, 4817 ZK Breda, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Orphan designation EMA/OD/122/13 (2013)8054 of 13/11/2013